Accelerating NLP Inference Models Using Processor Optimized Capabilities

AbbVie is a research-based biopharmaceutical company that serves more than 30 million patients in 175 countries. With its global scale, AbbVie partnered with Intel to optimize processes for its more than 47,000 employees.

Let’s look at two use cases that are important to AbbVie’s research. The first is Abbelfish Machine Translation, AbbVie’s language translation service based on the Transformer NLP model, that leverages the 2nd Generation Intel® Xeon® Scalable processors and the Intel® Optimization for TensorFlow with Intel® oneAPI Deep Neural Network Library (oneDNN).

The second use case is AbbVie Search, which is a BERT-based NLP model. AbbVie Search scans research documents based on scientific questions and returns relevant results that enable the discovery of new treatments for patients’ pharmaceuticals and manufacturing methods.

Download the whitepaper to find out how AbbVie uses Intel® Xeon® processors and the Intel® Distribution of OpenVINO toolkit to accelerate natural language processing models for biopharmaceutical research.

© Intel Corporation. Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others.

Download the whitepaper